Serum protein signatures as a non-invasive tool for monitoring nonalcoholic steatohepatitis

NASH and NAFLD are characterized by distinct sets of protein signatures. In our latest white paper, we discuss how researchers have used the SomaScan Assay to characterize and predict NASH non-invasively, even beating the best available clinical model. Download the white paper to learn more about how to get the most out of your NASH and NAFLD clinical samples with the world’s most impactful protein assay.

CONTINUE READING BY DOWNLOADING THE WHITEPAPER BELOW >>

 
 

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email